Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

17 terminated/withdrawn out of 901 trials

Success Rate

88.6%

+2.0% vs industry average

Late-Stage Pipeline

12%

104 trials in Phase 3/4

Results Transparency

8%

10 of 132 completed trials have results

Key Signals

252 recruiting10 with results10 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
244(39.8%)
Phase 2
163(26.6%)
Phase 1
81(13.2%)
Phase 4
53(8.6%)
Phase 3
51(8.3%)
Early Phase 1
21(3.4%)
613Total
N/A(244)
Phase 2(163)
Phase 1(81)
Phase 4(53)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (901)

Showing 20 of 901 trials
NCT06146946Not ApplicableRecruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Role: collaborator

NCT07548710Phase 2Recruiting

Study of SA+X in the Treatment of Newly Diagnosed AML

Role: lead

NCT07736131Completed

Learning Curve of SILS in CRC

Role: lead

NCT07733349Phase 1Not Yet Recruiting

Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease

Role: collaborator

NCT06519591Phase 2Recruiting

Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

Role: lead

NCT07735117Phase 3Not Yet Recruiting

Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML

Role: lead

NCT07272499Phase 2Recruiting

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Role: lead

NCT07669558Not ApplicableRecruiting

Electrical Impedance Tomography-Guided Identification of the Optimal Lateral Position in Postoperative ARDS

Role: lead

NCT06998706Phase 1Recruiting

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Interstitial Lung Disease (ILD): A Translational Application Study

Role: lead

NCT06987214Phase 1Recruiting

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study

Role: lead

NCT05694065Active Not Recruiting

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

Role: lead

NCT07726641Not ApplicableNot Yet Recruiting

Artificial Intelligence-Assisted Training for Novice Physicians in Electronic Nasopharyngolaryngoscopy

Role: lead

NCT07726875Enrolling By Invitation

Study on the Correlation Between Plasma Orexin Levels During the Recovery Period and Emergence Delirium in Elderly Patients: A Single-Center, Prospective, Observational Cohort Study

Role: lead

NCT07726654Not Yet Recruiting

The Longitudinal Cohort of Cerebral Small Vessel Disease in Ruijin Hospital

Role: lead

NCT07384234Phase 2Recruiting

SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

Role: lead

NCT07719855Phase 3Not Yet Recruiting

A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma

Role: lead

NCT07719218Phase 1Not Yet Recruiting

The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers

Role: lead

NCT03324698Active Not Recruiting

The Natural History of Chronic Pancreatitis

Role: collaborator

NCT07717177Phase 2Not Yet Recruiting

AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL

Role: lead

NCT06946953Phase 1Recruiting

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study

Role: lead